# Advantage Solutions Inc.: financial statements, quarterly

ADV · Nasdaq · CIK 1776661 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adv.md) · [Financials](/companies/adv/financials.md) · [Filings](/companies/adv/filings.md) · [Insiders](/companies/adv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/adv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,020](/filings/0000950170-24-124611.md) | [992 d](/filings/0001193125-26-088543.md) | [861](/filings/0000950170-25-069287.md) | [873](/filings/0000950170-25-104995.md) | [939](/filings/0001193125-25-269649.md) | [892 d](/filings/0001193125-26-088543.md) | [822](/filings/0001193125-26-209261.md) | [874](/filings/0001193125-26-334564.md) | [915](/filings/0001193125-25-269649.md) | [932 d](/filings/0001193125-26-088543.md) | [870](/filings/0001193125-26-209261.md) | [889](/filings/0001193125-26-334564.md) |
| Selling, general and administrative | $m | [68.3](/filings/0000950170-24-124611.md) | [78.1 d](/filings/0001193125-26-088543.md) | [89.1](/filings/0000950170-25-069287.md) | [62.9](/filings/0000950170-25-104995.md) | [98.4](/filings/0001193125-25-269649.md) | [74.2 d](/filings/0001193125-26-088543.md) | [64.9](/filings/0001193125-26-209261.md) | [68.7](/filings/0001193125-26-334564.md) | [57.6](/filings/0001193125-25-269649.md) | [85.0 d](/filings/0001193125-26-088543.md) | [53.3](/filings/0001193125-26-209261.md) | [50.9](/filings/0001193125-26-334564.md) |
| Operating income | $m | [6.7](/filings/0000950170-24-124611.md) | [20.7 d](/filings/0001193125-26-088543.md) | [(30.0)](/filings/0000950170-25-069287.md) | [(91.3)](/filings/0000950170-25-104995.md) | [(3.2)](/filings/0001193125-25-269649.md) | [(171) d](/filings/0001193125-26-088543.md) | [(14.6)](/filings/0001193125-26-209261.md) | [10.0](/filings/0001193125-26-334564.md) | [40.2](/filings/0001193125-25-269649.md) | [(162) d](/filings/0001193125-26-088543.md) | [4.2](/filings/0001193125-26-209261.md) | [1.7](/filings/0001193125-26-334564.md) |
| Interest expense | $m | [42.3](/filings/0000950170-23-060199.md) | [45.9 d](/filings/0000950170-24-023841.md) | [35.8](/filings/0000950170-24-057869.md) | [39.8](/filings/0000950170-24-094741.md) | [39.0](/filings/0001193125-25-269649.md) | [32.3 d](/filings/0001193125-26-088543.md) | [34.4](/filings/0001193125-26-209261.md) | [35.8](/filings/0001193125-26-334564.md) | [35.0](/filings/0001193125-25-269649.md) | [33.8 d](/filings/0001193125-26-088543.md) | [34.8](/filings/0001193125-26-209261.md) | [40.0](/filings/0001193125-26-334564.md) |
| Income tax | $m | [(6.6)](/filings/0000950170-24-124611.md) | [(21.7) d](/filings/0001193125-26-088543.md) | [(15.9)](/filings/0000950170-25-069287.md) | [(17.3)](/filings/0000950170-25-104995.md) | [(4.9)](/filings/0001193125-25-269649.md) | [(24.7) d](/filings/0001193125-26-088543.md) | [7.1](/filings/0001193125-26-209261.md) | [4.6](/filings/0001193125-26-334564.md) | [(15.3)](/filings/0001193125-25-269649.md) | [(34.1) d](/filings/0001193125-26-088543.md) | [23.3](/filings/0001193125-26-209261.md) | [21.8](/filings/0001193125-26-334564.md) |
| Net income | $m | [(24.3)](/filings/0000950170-24-124611.md) | [17.4 d](/filings/0001193125-26-088543.md) | [(5.3)](/filings/0000950170-25-069287.md) | [(101)](/filings/0000950170-25-104995.md) | [(42.8)](/filings/0001193125-25-269649.md) | [(178) d](/filings/0001193125-26-088543.md) | [(56.1)](/filings/0001193125-26-209261.md) | [(30.4)](/filings/0001193125-26-334564.md) | [20.6](/filings/0001193125-25-269649.md) | [(162) d](/filings/0001193125-26-088543.md) | [(71.8)](/filings/0001193125-26-209261.md) | [(62.7)](/filings/0001193125-26-334564.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0000950170-24-124611.md) | not reported | [(0.02)](/filings/0000950170-24-057869.md) | [(0.31)](/filings/0000950170-24-094741.md) | [(0.13)](/filings/0000950170-24-124611.md) | not reported | [(4.36)](/filings/0001193125-26-209261.md) | [(2.35)](/filings/0001193125-26-334564.md) | not reported | not reported | [(5.49)](/filings/0001193125-26-209261.md) | [(4.85)](/filings/0001193125-26-334564.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0000950170-24-124611.md) | not reported | [(0.02)](/filings/0000950170-24-057869.md) | [(0.31)](/filings/0000950170-24-094741.md) | [(0.13)](/filings/0000950170-24-124611.md) | not reported | [(4.36)](/filings/0001193125-26-209261.md) | [(2.35)](/filings/0001193125-26-334564.md) | not reported | not reported | [(5.49)](/filings/0001193125-26-209261.md) | [(4.85)](/filings/0001193125-26-334564.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [171](/filings/0000950170-23-060199.md) | [121](/filings/0001193125-26-088543.md) | [112](/filings/0000950170-24-057869.md) | [154](/filings/0000950170-24-094741.md) | [196](/filings/0000950170-24-124611.md) | [205](/filings/0001193125-26-088543.md) | [121](/filings/0000950170-25-069287.md) | [103](/filings/0000950170-25-104995.md) | [201](/filings/0001193125-25-269649.md) | [241](/filings/0001193125-26-334564.md) | [144](/filings/0001193125-26-209261.md) | [102](/filings/0001193125-26-334564.md) |
| Current assets | $m | [1,119](/filings/0000950170-23-060199.md) | [1,012](/filings/0000950170-25-035151.md) | [932](/filings/0000950170-24-057869.md) | [1,077](/filings/0000950170-24-094741.md) | [975](/filings/0000950170-24-124611.md) | [911](/filings/0001193125-26-088543.md) | [879](/filings/0000950170-25-069287.md) | [927](/filings/0000950170-25-104995.md) | [944](/filings/0001193125-25-269649.md) | [973](/filings/0001193125-26-334564.md) | [805](/filings/0001193125-26-209261.md) | [830](/filings/0001193125-26-334564.md) |
| Total assets | $m | [4,058](/filings/0000950170-23-060199.md) | [3,779](/filings/0000950170-25-035151.md) | [3,634](/filings/0000950170-24-057869.md) | [3,497](/filings/0000950170-24-094741.md) | [3,391](/filings/0000950170-24-124611.md) | [3,107](/filings/0001193125-26-088543.md) | [3,013](/filings/0000950170-25-069287.md) | [3,029](/filings/0000950170-25-104995.md) | [2,994](/filings/0001193125-25-269649.md) | [2,793](/filings/0001193125-26-334564.md) | [2,565](/filings/0001193125-26-209261.md) | [2,540](/filings/0001193125-26-334564.md) |
| Current liabilities | $m | [634](/filings/0000950170-23-060199.md) | [541](/filings/0000950170-25-035151.md) | [477](/filings/0000950170-24-057869.md) | [509](/filings/0000950170-24-094741.md) | [513](/filings/0000950170-24-124611.md) | [460](/filings/0001193125-26-088543.md) | [442](/filings/0000950170-25-069287.md) | [473](/filings/0000950170-25-104995.md) | [429](/filings/0001193125-25-269649.md) | [433](/filings/0001193125-26-334564.md) | [412](/filings/0001193125-26-209261.md) | [463](/filings/0001193125-26-334564.md) |
| Total liabilities | $m | [2,877](/filings/0000950170-23-060199.md) | [2,675](/filings/0000950170-25-035151.md) | [2,550](/filings/0000950170-24-057869.md) | [2,524](/filings/0000950170-24-094741.md) | [2,459](/filings/0000950170-24-124611.md) | [2,358](/filings/0001193125-26-088543.md) | [2,318](/filings/0000950170-25-069287.md) | [2,345](/filings/0000950170-25-104995.md) | [2,285](/filings/0001193125-25-269649.md) | [2,239](/filings/0001193125-26-334564.md) | [2,087](/filings/0001193125-26-209261.md) | [2,138](/filings/0001193125-26-334564.md) |
| Long-term debt | $m | [1,910](/filings/0000950170-23-060199.md) | [1,848](/filings/0000950170-25-035151.md) | [1,796](/filings/0000950170-24-057869.md) | [1,769](/filings/0000950170-24-094741.md) | [1,688](/filings/0000950170-24-124611.md) | [1,687](/filings/0001193125-26-088543.md) | [1,665](/filings/0000950170-25-069287.md) | [1,664](/filings/0000950170-25-104995.md) | [1,662](/filings/0001193125-25-269649.md) | [1,661](/filings/0001193125-26-334564.md) | [1,521](/filings/0001193125-26-209261.md) | [1,516](/filings/0001193125-26-334564.md) |
| Current portion of debt | $m | [14.4](/filings/0000950170-23-060199.md) | [13.3](/filings/0000950170-25-035151.md) | [13.3](/filings/0000950170-24-057869.md) | [13.3](/filings/0000950170-24-094741.md) | [13.3](/filings/0000950170-24-124611.md) | [13.3](/filings/0001193125-26-088543.md) | [13.3](/filings/0000950170-25-069287.md) | [13.3](/filings/0000950170-25-104995.md) | [13.3](/filings/0001193125-25-269649.md) | [13.3](/filings/0001193125-26-334564.md) | [25.9](/filings/0001193125-26-209261.md) | [25.3](/filings/0001193125-26-334564.md) |
| Shareholders' equity | $m | [1,072](/filings/0000950170-23-060199.md) | [1,105](/filings/0000950170-25-035151.md) | [1,083](/filings/0000950170-24-057869.md) | [974](/filings/0000950170-24-094741.md) | [933](/filings/0000950170-24-124611.md) | [749](/filings/0000950170-25-035151.md) | [696](/filings/0001193125-26-334564.md) | [684](/filings/0001193125-26-334564.md) | [708](/filings/0001193125-25-269649.md) | [554](/filings/0001193125-26-334564.md) | [478](/filings/0001193125-26-334564.md) | [402](/filings/0001193125-26-334564.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [75.8 d](/filings/0000950170-24-124611.md) | [47.7 d](/filings/0001193125-26-088543.md) | [(9.4)](/filings/0000950170-25-069287.md) | [53.4 d](/filings/0000950170-25-104995.md) | [34.0 d](/filings/0001193125-25-269649.md) | [15.1 d](/filings/0001193125-26-088543.md) | [(39.6)](/filings/0001193125-26-209261.md) | [(8.1) d](/filings/0001193125-26-334564.md) | [63.6 d](/filings/0001193125-25-269649.md) | [45.6 d](/filings/0001193125-26-088543.md) | [23.7](/filings/0001193125-26-209261.md) | [(6.5) d](/filings/0001193125-26-334564.md) |
| Capital expenditure | $m | [10.4 d](/filings/0000950170-24-124611.md) | [(3.7) d](/filings/0001193125-26-088543.md) | [15.4](/filings/0000950170-25-069287.md) | [9.6 d](/filings/0000950170-25-104995.md) | [25.3 d](/filings/0001193125-25-269649.md) | [(42.5) d](/filings/0001193125-26-088543.md) | [15.1](/filings/0000950170-25-069287.md) | [2.1 d](/filings/0000950170-25-104995.md) | [11.4 d](/filings/0001193125-25-269649.md) | [(22.2) d](/filings/0001193125-26-088543.md) | [11.4](/filings/0001193125-26-209261.md) | [9.4 d](/filings/0001193125-26-334564.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-124611.md) | [6.4 d](/filings/0001193125-26-088543.md) | [11.7](/filings/0000950170-25-069287.md) | [9.1 d](/filings/0000950170-25-104995.md) | [13.3 d](/filings/0001193125-25-269649.md) | [0.0 d](/filings/0001193125-26-088543.md) | [0.9](/filings/0001193125-26-209261.md) | [0.0 d](/filings/0001193125-26-334564.md) | [0.0 d](/filings/0001193125-25-269649.md) | [0.0 d](/filings/0001193125-26-088543.md) | [2.3](/filings/0001193125-26-209261.md) | [14.7 d](/filings/0001193125-26-334564.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [320](/filings/0000950170-23-060199.md) | [321](/filings/0000950170-24-057869.md) | [324](/filings/0000950170-24-094741.md) | [325](/filings/0000950170-24-124611.md) | [321](/filings/0000950170-25-069287.md) | [323](/filings/0000950170-25-104995.md) | [321](/filings/0001193125-25-269649.md) | [12.9](/filings/0001193125-26-209261.md) | [13.0](/filings/0001193125-26-334564.md) | [340](/filings/0001193125-25-269649.md) | [13.1](/filings/0001193125-26-209261.md) | [12.9](/filings/0001193125-26-334564.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,822,230 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-334564.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.